Stockreport

Bausch wins US appeal to block Alvogen generic of diarrhea drug [Yahoo! Finance]

Bausch + Lomb Corporation  (BLCO) 
PDF Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029. A Delaware federal court had determined that Alvogen subsidiary No [Read more]